RECRUITINGINTERVENTIONAL
Caffeine and Cataract After Pars Plana Vitrectomy
The Effect of Caffeine Consumption on Cataract Formation After Pars Plana Vitrectomy: a Comparative Study
About This Trial
Assessment of cataract development in patients with regular caffeine consumption and those without caffeine consumption after pars plana vitrectomy.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 18 or older
- Written willing to sign a consent form
- No previous cataract surgery in the study eye
- Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) due to retinal detachment or macular hole repair
- No regular caffeine consumption (drinking not more than one cup of a caffeine- containing beverage \[e.g. coffee, energy drinks\] at a maximum of two days per week during the past year)
Who Should NOT Join This Trial:
- Intake of systemic or topical corticosteroids within 3 months before study screening
- Increased risk for postoperative cataract development, for example due to ocular trauma in the history
- Severe cataract (LOCS III grading of any cataract form \>2) in the study eye at pre- study screening
- Scheduled phacovitrectomy in the study eye
- Participation in any clinical trial three month before study screening
- Ocular surgeries six month before study screening
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 18 or older
* Written informed consent
* No previous cataract surgery in the study eye
* Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) due to retinal detachment or macular hole repair
* No regular caffeine consumption (drinking not more than one cup of a caffeine- containing beverage \[e.g. coffee, energy drinks\] at a maximum of two days per week during the past year)
Exclusion Criteria:
* Intake of systemic or topical corticosteroids within 3 months before study screening
* Increased risk for postoperative cataract development, for example due to ocular trauma in the history
* Severe cataract (LOCS III grading of any cataract form \>2) in the study eye at pre- study screening
* Scheduled phacovitrectomy in the study eye
* Participation in any clinical trial three month before study screening
* Ocular surgeries six month before study screening
Treatments Being Tested
PROCEDURE
Pars plana vitrectomy
Standard pars plana vitrectomy will be performed
Locations (1)
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna
Vienna, Austria